Ocugen (NASDAQ: OCGN) insider transactions
In the twelve months to 10 November 2026, executives and directors of Ocugen reported 4 open-market sales of 1,051,982 shares ($1.1m) and 1 open-market purchase of 21,000 shares ($25,830), by 2 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 9 October 2026 | Musunuri Shankar | Chief Executive Officer | Open-market sale, 10b5-1 plan | −468,727 | $0.95 | 4,018,470 | Form 4 |
| 9 October 2026 | Musunuri Shankar | Chief Executive Officer | Open-market sale, 10b5-1 plan | −57,264 | $0.95 | 1,030,771 | Form 4 |
| 9 September 2026 | Musunuri Shankar | Chief Executive Officer | Open-market sale, 10b5-1 plan | −468,727 | $1.12 | 4,487,197 | Form 4 |
| 9 September 2026 | Musunuri Shankar | Chief Executive Officer | Open-market sale, 10b5-1 plan | −57,264 | $1.12 | 1,088,035 | Form 4 |
| 15 June 2026 | Johnson-Greene Treerita Essalima | Chief Financial Officer | Open-market purchase | +21,000 | $1.23 | 521,000 | Form 4 |
| 1 April 2026 | Zhang Junge | Director | Option exercise | +15,000 | $0.51 | 1,180,182 | Form 4 |
| 1 April 2026 | Zhang Junge | Director | Option exercise | +112,205 | $0.46 | 1,292,387 | Form 4 |
| 1 April 2026 | Zhang Junge | Director | Option exercise | +66,929 | $1.42 | 1,359,316 | Form 4 |
| 2 January 2026 | Ramachandran Ramesh | Chief Accounting Officer | Grant or award | +207,300 | — | 209,100 | Form 4 |
| 2 January 2026 | Musunuri Shankar | Chief Executive Officer | Grant or award | +3,123,201 | — | 4,955,924 | Form 4 |
| 3 January 2025 | Musunuri Shankar | Chief Executive Officer | Shares withheld for tax | −177,146 | $0.89 | 1,832,723 | Form 4 |
| 3 January 2025 | Upadhyay Arun | See Remarks | Shares withheld for tax | −41,633 | $0.89 | 306,197 | Form 4 |
| 26 November 2024 | Fernandes Prabhavathi | Director | Open-market purchase | +10,000 | $0.91 | 10,000 | Form 4 |
| 22 November 2024 | Castillo Kirsten | Director | Open-market purchase | +25,000 | $0.91 | 75,000 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Ocugen page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.